✦ LIBER ✦

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Scribed by Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Serge D. Steinfeld; Ernest H.S. Choy; John T. Sharp; Peter A. Ory; Renee J. Perdok; Mark A. Weinberg

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 128 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Alefacept in combination with methotrexa

Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study

✍ Philip J. Mease; Dafna D. Gladman; Edward C. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, double‐blind, placebo‐controlled trial if they were ages 18–70 years and had act

Pregabalin for the treatment of fibromya

Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial

✍ Leslie J. Crofford; Michael C. Rowbotham; Philip J. Mease; I. Jon Russell; Rober 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Efficacy of methotrexate treatment in pa

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto